featured
Everolimus Plus Exemestane for HR+ Advanced Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The Oncologist
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Everolimus Plus Exemestane for Hormone Receptor-Positive Advanced Breast Cancer: A PAM50 Intrinsic Subtype Analysis of BOLERO-2
Oncologist 2019 Jan 24;[EPub Ahead of Print], A Prat, JC Brase, Y Cheng, P Nuciforo, L Paré, T Pascual, D Martínez, P Galván, M Vidal, B Adamo, GN Hortobagyi, J Baselga, E CiruelosFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.